InspireMD (NSPR) Current Leases (2021 - 2022)
InspireMD (NSPR) posted quarterly Current Leases of $416000.0 for Q3 2022, down 0.95% quarter-over-quarter from $420000.0 in Q4 2021.
InspireMD (NSPR) Current Leases (2021 - 2022) Analysis & Trends
InspireMD's Current Leases history runs 2 years deep, the most recent figure standing at $416000.0 for Q3 2022.
- In Q3 2022, Current Leases changed N/A year-over-year to $416000.0; the TTM figure through Sep 2022 stood at $416000.0 (changed N/A YoY), while the FY2021 annual figure was $420000.0, changed N/A from the prior year.
- Current Leases for Q3 2022 stood at $416000.0, down from $420000.0 in the prior quarter.
- The five-year high for Current Leases was $420000.0 in Q4 2021, with the low at $416000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 24.10 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 20.70 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | - |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 35.60 Mn |
| 10 | InspireMD | 58.53 Mn | 4.32 Mn | 1.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 416,000.00 |
| Dec 31, 2021 | 420,000.00 |